At World Atrial Fibrillation Awareness Day on September 14, 2013, Dr. James Cox received the Global Atrial Fibrillation Alliance Physician Ambassador of the Year Award and Mellanie True Hills received the Global Atrial Fibrillation Alliance Patient Ambassador of the Year Award. Hospital and Industry Ambassador of the Year Awards were also presented. Learn more at …
Read More
During Atrial Fibrillation Awareness Month, StopAfib.org highlights a new video that explains the hidden afib risks. Learn more at: New StopAfib.org Video Explains the Hidden Afib Risks for Atrial Fibrillation Awareness Month
Read More
What you don't know about atrial fibrillation could kill you, or a loved one! Atrial fibrillation (also called afib) is an irregular heartbeat (or heart rhythm), and is a major cause of strokes. Having afib increases your stroke risk by 500 percent. In addition, afib can lead to heart failure, dementia, and even Alzheimer's disease. …
Read More
Here is an update on the DECAAF study that Dr. Nassir Marrouche presented at the European Society of Cardiology in Amsterdam today. According to Dr. Marrouche, the amount of fibrosis (scar tissue created in the heart by atrial fibrillation), as measured on pre-ablation MRIs (magnetic resonance imaging), predicts the success of catheter ablations for atrial …
Read More
As reported at the European Society of Cardiology in Amsterdam, among patients with 0-2 stroke risk factors, those with atrial fibrillation had a three-fold risk of stroke over those who didn’t have afib. But that difference declined as the number of risk factors increased. The risk of stroke was high in those with 3 or …
Read More
We’re finally getting a glimpse into what to expect from edoxaban, the 4th new anticoagulant medication. At the European Society of Cardiology in Amsterdam, it was reported that edoxaban was safer--in other words, had less bleeding--than warfarin for those with deep vein thrombosis (blood clots in the legs) or pulmonary embolism (blood clots in the …
Read More
This confirms what we already knew... As reported today at the European Society of Cardiology in Amsterdam: "Women with AF receive less anticoagulation treatment than men despite the fact that they are at greater risk of stroke. The new CHA2DS2-VASc score should be used more stringently, especially in women, to optimise their treatment. Treatment of …
Read More
People with atrial fibrillation may develop age-related cognitive decline (thinking and memory problems) at a younger age than those without afib, a new study says. We already knew that cognitive decline becomes more common as people get older, and that afib may have contributed to this cognitive decline. But we didn't know for sure until …
Read More
StopAfib.org interviews Dr. Andy Kiser of the University of North Carolina Find more on Dr. Kiser, and a transcript of the interview at: http://www.stopafib.org/newsitem.cfm/NEWSID/467 In this video interview, Dr. Andy Kiser discusses the hybrid ablation (also called the hybrid procedure) in which cardiac surgeons and electrophysiologists collaborate to do a surgical ablation and a catheter …
Read More
On Today’s Inspiring Women, host Deanne DeMarco interviewed Loretta Rosenmayer, CEO of Trench-It, and Mellanie True Hills, Founder and CEO of StopAfib.org. Mellanie’s interview starts at about 31 minutes into the program; however, if you happen to be a young woman in business, you’ll also enjoy listening to the interview with Loretta Rosenmayer, a very …
Read More